Triple Versus Dual Antiplatelet Therapy After Coronary Stenting-Reference-Cited by-同舟云学术

Triple Versus Dual Antiplatelet Therapy After Coronary Stenting

Published:2005-11 Issue:10 Volume:46 Page:1833-1837
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Lee Seung-Whan,Park Seong-Wook,Hong Myeong-Ki,Kim Young-Hak,Lee Bong-Ki,Song Jong-Min,Han Ki Hoon,Lee Cheol Whan,Kang Duk-Hyun,Song Jae-Kwan,Kim Jae-Joong,Park Seung-Jung

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference15 articles.

1. Effects of cilostazol, a selective cAMP phosphodiesterase inhibitor, on the contraction of vascular smooth muscle;Tanaka;Pharmacology,1988

2. A randomized trial of aspirin versus cilostazol therapy after successful coronary stent implantation;Kunishima;Clin Ther,1997

3. Comparison of cilostazol versus ticlopidine therapy after stent implantation;Park;Am J Cardiol,1999

4. Comparison of cilostazol and clopidogrel after successful coronary stenting;Lee;Am J Cardiol,2005

5. Effects of cilostazol on platelet activation in coronary stenting patients who already treated with aspirin and clopidogrel;Ahn;Korean J Intern Med,2004

Cited by 182 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of cilostazol-based triple antiplatelet therapy compared with clopidogrel-based dual antiplatelet therapy in patients with acute ST-elevation myocardial infarction undergoing percutaneous coronary intervention: A multicenter, randomized, open-label, phase 4 trial;American Heart Journal;2023-11

2. Effect of Cilostazol on Patients With Diabetes Who Underwent Endovascular Treatment for Peripheral Artery Disease;Journal of the American Heart Association;2023-06-20

3. Comparison of Clinical Outcomes after Non-ST-Segment and ST-Segment Elevation Myocardial Infarction in Diabetic and Nondiabetic Populations;Journal of Clinical Medicine;2022-08-29

4. Evaluation of Efficacy and Safety of Paclitaxel and Cilostazol Dual Drug-eluting Coronary Stents;Journal of Cardiovascular Intervention;2022

5. Two‐year outcomes between ST‐elevation and non‐ST‐elevation myocardial infarction in patients with chronic kidney disease undergoing newer‐generation drug‐eluting stent implantation;Catheterization and Cardiovascular Interventions;2021-12-28